ARALU - Phase 2, Open-label, Randomized Study to Investigate Safety and Efficacy of Pluvicto Therapy in Patients with Metastatic Hormone-sensitive Prostate Cancer in Addition to Standard of Care Treatment with Nubeqa and ADT

European Urology Focus · Elsevier

Аннотация

Publication date: October 2026 Source: European Urology Focus, Volume 12, Issue 5 Author(s): Julia Franz, Joachim Brumberg, Michael Mix, Philipp T. Meyer, Ken Herrmann, Christian Gratzke, August Sigle

Читать у издателя →

Похожие статьи